Birdwatch Note
2023-04-18 23:18:29 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
The US Food and Drug Administration (FDA) has authorized the use of the mRNA bivalent (original and Omicron BA.4/BA.5) COVID-19 vaccine (Moderna and Pfizer-BioNTech) for all doses administered to individuals 6 months of age and older. https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-changes-simplify-use-bivalent-mrna-covid-19-vaccines https://www.prnewswire.com/news-releases/coronavirus-covid-19-update-fda-authorizes-changes-to-simplify-use-of-bivalent-mrna-covid-19-vaccines-301800433.html https://www.empr.com/home/news/fda-use-bivalent-covid-19-vaccines-monovalent-ones-no-longer-authorized/
Written by 959C165EC37A9318F088F21ED4E7DEF09A8E4DC765A53F7F64C77595ADA32409
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1648450263827763201
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1648466054816075781
- noteId - 1648466054816075781
- participantId -
- noteAuthorParticipantId - 959C165EC37A9318F088F21ED4E7DEF09A8E4DC765A53F7F64C77595ADA32409 Participant Details
- createdAtMillis - 1681859909143
- tweetId - 1648450263827763201
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 0
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 0
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- The US Food and Drug Administration (FDA) has authorized the use of the mRNA bivalent (original and Omicron BA.4/BA.5) COVID-19 vaccine (Moderna and Pfizer-BioNTech) for all doses administered to individuals 6 months of age and older. https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-changes-simplify-use-bivalent-mrna-covid-19-vaccines https://www.prnewswire.com/news-releases/coronavirus-covid-19-update-fda-authorizes-changes-to-simplify-use-of-bivalent-mrna-covid-19-vaccines-301800433.html https://www.empr.com/home/news/fda-use-bivalent-covid-19-vaccines-monovalent-ones-no-longer-authorized/
Note Ratings
rated at | rated by | |
2023-04-18 20:43:47 -0500 | Rating Details | |
2023-04-19 02:08:25 -0500 | Rating Details | |
2023-04-18 20:37:16 -0500 | Rating Details | |
2023-04-18 21:23:53 -0500 | Rating Details | |
2023-04-18 20:02:07 -0500 | Rating Details | |
2023-04-19 00:25:47 -0500 | Rating Details | |
2023-04-18 20:18:56 -0500 | Rating Details | |
2023-04-19 15:54:46 -0500 | Rating Details | |
2023-04-18 22:09:55 -0500 | Rating Details | |
2023-04-19 00:32:06 -0500 | Rating Details | |
2023-04-18 20:47:12 -0500 | Rating Details | |
2023-04-19 00:02:00 -0500 | Rating Details | |
2023-04-19 03:23:40 -0500 | Rating Details | |
2023-04-18 18:42:47 -0500 | Rating Details | |
2023-04-18 20:54:33 -0500 | Rating Details | |
2023-04-19 04:34:46 -0500 | Rating Details | |
2023-04-19 02:18:32 -0500 | Rating Details | |
2023-04-18 20:43:47 -0500 | Rating Details | |
2023-04-19 02:08:25 -0500 | Rating Details | |
2023-04-18 20:37:16 -0500 | Rating Details | |
2023-04-18 21:23:53 -0500 | Rating Details | |
2023-04-18 20:02:07 -0500 | Rating Details | |
2023-04-19 00:25:47 -0500 | Rating Details | |
2023-04-18 20:18:56 -0500 | Rating Details | |
2023-04-19 15:54:46 -0500 | Rating Details | |
2023-04-18 22:09:55 -0500 | Rating Details | |
2023-04-19 00:32:06 -0500 | Rating Details | |
2023-04-18 20:47:12 -0500 | Rating Details | |
2023-04-19 00:02:00 -0500 | Rating Details | |
2023-04-19 03:23:40 -0500 | Rating Details | |
2023-04-18 18:42:47 -0500 | Rating Details | |
2023-04-18 20:54:33 -0500 | Rating Details | |
2023-04-19 04:34:46 -0500 | Rating Details | |
2023-04-19 02:18:32 -0500 | Rating Details |